Abstract

The outbreak and impacts of coronavirus (COVID-19, SARS-Co-2) is still a mystery. Yet a sign of prospective epidemics cannot be ruled out. The current studies of COVID-19 (public health, medical and pharmaceutical) implied a benefit of diagnostic/therapeutic transition. To heighten global campaign for COVID-19 studies, global public healthcare and pharmaceutical strategies are highlighted herein. In the past, epidemic condition, countrywide stipulation and therapeutic variability worldwide were confronted before us. Different patterns of medical experience and pharmaceutical trends should be enhanced in the future.

Keywords

COVID-19, viral treatment, viral structure, herbal medicine, viral vaccines